Symrise AG · XETR:SY1
Symrise — Premium Review Conference Paris (November 2018)
20 slides from Symrise's conference presentation, November 2018

Slide 1: Unfolding strengths
DISCLAIMER: ”The following document contains protected and confidential information from Symrise and must be kept in confidence. This information may not be used by anyone who obtains it if Symrise has not granted written permission to do so.” Unfolding strengths Symrise AG Olaf Klinger (CFO), Novem

Slide 2: A high quality growth play
A high quality growth play Investment highlights 3) A strategy with focus on 1) Attractive industry 2) Strongly balanced portfolio across industry- geared towards defensive businesses, regions leading end-consumer markets and customers growth 5) A portfolio 4) Competitive edge thanks to 6) Backward

Slide 3: 1) Attractive industry
1) Attractive industry Geared towards defensive end-consumer markets Who we serve What our industry is like Which trends we benefit from Health & wellness F&F Local E-commerce & Food & stars online brands beverages Characteristics End-consumer trends Oligopolistic: top 4 > 60% Global player Pet food

Slide 4: 2) Strongly balanced portfolio
2) Strongly balanced portfolio Across businesses, regions and customers In % of Group sales (2017) Scent & Care 42% Flavor 37% Nutrition 21% Fragrance Cosmetic Ingredients Aroma Molecules Food Fine Fragrances Sweet Beauty Cosmetic Pet Food Care Actives Savory Home Aqua Care Oral Sun Care Protection

Slide 5: 3) A strategy with focus on industry-leading growth
3) A strategy with focus on industry-leading growth How we want to grow Leverage Grow in Expand naturals Drive innovation Maximize internal growth emerging & sustainable across segments customer base opportunities markets solutions offering 6% of sales >50% >10% 1/3 mix global, 100% traceability inv

Slide 6: 4) Competitive edge thanks to cross-linking competencies & leading R&D engine
4) Competitive edge thanks to Cross-linking competencies & leading R&D engine Cross-divisional work for top 10 clients Recent innovations and R&D projects Patent Index: Most innovative F&F players* A Natural cosmetic actives that B strengthen skin barrier C 10,1% 33,8% Pet product solutions for D be

Slide 7: 5) Beyond traditional F&F
5) Beyond traditional F&F Building a unique portfolio Internal growth – capex pipeline 2018/19 Our portfolio today Business Project Investment (in € m) Start Pet Food New spray dryer and cookers for Elven 20 Mar-2018 Cosmetic Ingredients Multi-purpose production facility Bushy Park 20 Aug-2018 Food

Slide 8: 5a) Scent & Care using Artificial Intelligence
5a) Scent & Care using Artificial Intelligence IBM Research and Symrise breaking new fragrance ground — The start of the digital age for the perfume industry. An archive of formulas and historical data help with the creation of fragrances. — In partnership with IBM Research a method has been develop

Slide 9: 5b) Scent & Care expanding Cosmetic Ingredients
5b) Scent & Care expanding Cosmetic Ingredients New natural derived product successfully launched — New multi-functional cosmetic from renewable resources. By-product from sugar cane. — ‘Hydrolite®5 green’ combines efficacy and naturalness to meet market expectations – important innovation milestone

Slide 10: 5c) Nutrition invests €50m in new US facility in Georgia
5c) Nutrition invests €50m in new US facility in Georgia New site for high-quality natural food ingredients — Location in the USA’s well-developed agricultural South-East enables accelerated growth with natural food ingredients. — Strengthening of competitiveness by building new capacities in worlds

Slide 11: 6) Backward integration
6) Backward integration Serving the trend towards naturals & traceability 1. Strategic acquisitions that 4. Long-term contracts and enable us to move closer to the origin of the sustainability partnerships with raw materials we process. commitment to purchase e.g. for d/l- menthol or bergamot. 3. Pa

Slide 12: Proven strategy succeeds in different market dynamics
Proven strategy succeeds in different market dynamics Corporate strategy — Long-term growth drivers are intact. Vision Growing global population, urbanization, economic progress and increasing awareness of balanced nutrition and personal care — Growth Efficiency Portfolio Backward integration and ow

Slide 13: Our ambition: Financial track record and targets
Our ambition Financial track record and targets Growth and margin track record since IPO Targets 2018 Targets until 2020 In €m 21,3% 21,1% 21,0% 20,0% 22% EBITDA Margin 21,9% 22,0% 21,5% 19% 19,8% 19,5% 20,4% 19,9% 18,0% Outlook raised on Nov 7 to >8% 5-7% 2.903 2.966 Organic sales growth 2.602 CAGR

Slide 14: 9M 2018 – Operational and financial highlights
9M 2018 – Operational and financial highlights Positive business performance / Raising the outlook Organic growth & EBITDA margin by segment Sales In % 9M 2018 (9M 2017) EBITDA margin €2,382.6bn 20.0% EBITDA €375.7m 8,8% 9,2% 10,2% 7.6% ex. Probi 5,7% +8.8% Raising 2018 organic sales outlook growth

Slide 15: Symrise Group remains on dynamic growth track
Symrise Group Remains on dynamic growth track Sales EBITDA & EBIT In € m In € m 9M 2017 9M 2018 Change % 8,8% 1,5% -132,1 4,6% EBITDA 485.2 475.7 -2.0 201,5 34,8 -5,8% EBITDA margin in % 21.3 20.0 EBIT 337.2 329.3 -2.3 EBIT margin in % 14.8 13.8 Comments 2.278,4 2.382,6 Organic sales growth of 8.8%

Slide 16: Scent & Care
Scent & Care Strong growth despite tense supply situation Sales EBITDA In € m In € m 0,8% -57,3 9M 2017 9M 2018 Change % 9,2% 4,0% 7,3 EBITDA 196.2 191.8 -2.3 88,4 -6,0% EBITDA margin in % 20.4 19.2 Comments 960,1 998,6 Strong organic growth of 9.2% offset by FX headwinds. Portfolio effect of 0.8 %

Slide 17: Flavor
Flavor Double-digit organic sales growth Sales EBITDA In € m In € m 9M 2017 9M 2018 Change % 3,3% -43,7 10,2% 8,3% EBITDA 183.4 187.0 +1.9 27,5 EBITDA margin in % 21.8 20.5 -5,2% 86,1 Comments 842,6 912,5 Double-digit organic growth of 10.2% driven by all business units. — LATAM with strongest growt

Slide 18: Nutrition
Nutrition Probi order intake normalized Sales EBITDA In € m In € m 9M 2017 9M 2018 Change % 5,7% -31,2 -0,9% EBITDA 105.6 96.9 -8.2 26,9 EBITDA margin in % 22.2 20.5 -6,6% Comments 475,7 471,4 Good organic growth of 5,7% - Q3 plus 10,0% - Probi returned to quarter-on-quarter organic growth in Q3 aft

Slide 19: Targets 2018 and until 2020
Targets 2018 and until 2020 Sales target 2018 further increased Targets Mid-term Targets 2018 2020 10 - >8% 5 –7% Growth 5- Symrise Organic rate 3-4% Growth Market (CAGR) growth 0 ~20% 19 –22% EBITDA EBITDA margin margin 19

Slide 20: Contact Investor Relations
Contact Investor Relations Financial Calendar Disclaimer Jan 17/18, 2019 This document contains forward-looking statements, which are based on the current estimates and assumptions by Capital Market Days, USA (SC, GA, FL) the corporate management of Symrise AG. Forward-looking statements are charact
Source: Internet Archive copy of symrise.com
More decks from Symrise AG
Q3 2026 Earnings Presentation22 slides · Oct 28, 2026
Investor Presentation (October 2026)39 slides · October 2026
H1 2026 Earnings Presentation25 slides · Jul 30, 2026
Q2 2026 Earnings Presentation29 slides · Jul 30, 2026
Shareholder Meeting (May 2026)19 slides · May 6, 2026
Q1 2026 Earnings Presentation19 slides · Apr 29, 2026